The role of cell cycle-mediated events in Alzheimer's disease

International Journal of Experimental Pathology

Volumn 80, Issue 2, 1999, Pages 71-76

  Raina, Arun K ^a   Monteiro, Mervyn J ^b   Mcshea, Andrew ^c   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Alzheimer's disease; APP; Mitosis; Neoplasia; Oxidative stress; Presenilin

Indexed keywords

PRESENILIN 1;

ALZHEIMER DISEASE; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL MATURATION; DNA REPLICATION; GENE EXPRESSION; HIPPOCAMPUS; MITOSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CELL CYCLE; HUMANS; NEURONS; OXIDATIVE STRESS;

EID: 0032892435     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1999.00106.x     Document Type: Review

References (63)

1. ALCORTA D.A., XIONG Y., PHELPS D., HANNON G., BEACH D. & BARRETT J.C. (1996) Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proceedings Natl. Acad. Sci. USA 93, 13742-13747.
2. ARENDT T., HOLZER M. & GARTNER U. (1998) Neuronal expression of cyctine dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J. Neural Transm. 105, 949-960.
3. ARENDT T., HOLZER M., GROSSMANN A., ZEDLICK D. & BRUCKNER M.K. (1995) Increased expression and subcellular translocation of the mitogen activated protein kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience 68, 5-18.
4. ARENDT T., RODEL L., GARTNER U. & HOLZER M. (1996) Expression ot the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 7, 3047-3049.
5. BARNI S., SCIOLA L., SPANO A. & PIPPIA P. (1996) Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts. Biotech. Histochem. 71, 66-70.
6. BAUMANN K., MANDELKOW E.M., BIERNAT J., PIWNICA-WORMS H. & MANDELKOW E. (1993) Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 336, 417-424.
7. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule bindings. Neuron 10, 1089-1099.
8. BRION J.P., OCTAVE J.N. & COUCK A.M. (1994) Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience 63, 895-909.
9. BRION J.P., PASSARIER H., NUNEZ J. & FLAMENT-DURAND J. (1985) Immunologie determinants of tau protein are present in neurofibrillary tangles of Alzheimer's disease. Arch. Biol. 95, 229-235.
10. CASTELLANI R., SMITH M.A., RICHEY P.L., KALARIA R., GAMBETTI P. & PERRY G. (1995) Evidence for oxidative stress in Pick disease and corticobasal degeneration. Brain Res. 696, 268-271.
11. CASTELLANI R., SMITH M.A., RICHEY P.L. & PERRY G. (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 737, 195-200.
12. CRUTCHER K.A., SCOTT S.A., LIANG S., EVERSON W.V. & WEINGARTNER J. (1993) Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J. Neurosci 13, 2540-2550.
13. CURCIO F. & CERIELLO A. (1992) Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications in vitro. Cell. Dev. Biol. 28A, 787-790.
14. DENG G., PIKE C.J. & COTMAN C.W. (1996) Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells. FEBS Lett. 397, 50-54.
15. DEWJI N.N. & SINGER S.J. (1997) Cell surface expression of the Alzheimer disease-related presenilin proteins. Proceedings. Natl. Acad. Sci. USA 94, 9926-9931.
16. ELLEDGE S.J. (1996) Cell cycle checkpoints: Preventing an identity crisis. Science 274, 1664-1672.
17. EVAN G.I., BROWN L., WHYTE M. & HARRINGTON E. (1995) Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7, 825-834.
18. EVAN G. & LITTLEWOOD T. (1998) A matter of life and cell death. Science 281, 1317-1322.
19. FERRARI G., VAN C.Y. & GREENE L.A. (1995) N-acetylcysteine (D-and L-stereoisomers) prevents apoptotic death of neuronal cells. J. Neurosci. 15, 2857-2866.
20. FREEMAN R.S., ESTUS S. & JOHNSON E.M. JR (1994) Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell death. Neuron 12, 343-355.
21. GARTNER U., HOLZER M., HEUMANN R. & ARENDT T. (1995) Induction of p21ras in Alzheimer pathology. Neuroreport 6, 1441-1444.
22. GOMEZ-PINILLA F., CUMMINGS B.J. & COTMAN C.W. (1990) Induction of basic fibroblast growth factor in Alzheimer's disease pathology. Neuroreport 1, 211 -214.
23. GUO Q., FURUKAWA K., SOPHER B.L. ET AL. (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 8, 379-383.
24. GUO Q., SOPHER B.L., FURUKAWA K. ET AL. (1997) Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J. Neurosci. 11, 4212-4222.
25. HARDY J. (1997) Amyloid, the presenilins and Alzheimer's disease Trends Neurosci. 20, 155-159.
26. HIRAI K., SMITH M.A., WADE R. & PERRY G. (1998) Vulnerable neurons in Alzheimer disease accumulate mitochondrial DNA with the common 5kb deletion. J. Neuropathol. Exp. Neurol. 57, 511.
27. JANICKI S. & MONTEIRO M.J. (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N1411). J. Cell Biol. 139, 485-495.
28. KOVACS D.M., FAUSETT H.J., PAGE K.J. ET AL. (1996) Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2, 224-229.
29. LEDESMA M.D., CORREAS I., AVILA J. & DIAZ-NIDO J. (1992) Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett. 308, 218-224.
30. LEVITAN D. & GREENWALD I. (1995) Facilitation of lin-12-mediated signaling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354.
31. LI J., XU M., ZHOU H., MA J. & POTTER H. (1997) Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90, 917-927.
32. MATTSON M.P., GUO Q., FURUKAWA K. & PEDERSEN W.A. (1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70, 1-14.
33. MCSHEA A., HARRIS P.L.R., WEBSTER K.R., WAHL A.F. & SMITH M.A. (1997) Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150, 1933-1939.
34. MCSHEA A., ZELASKO D.A., GERST J.L. & SMITH M.A. (1999a) Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Res. 815, 237-242.
35. MCSHEA A., WAHL A.F. & SMITH M.A. (1999b) Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. Med. Hypotheses in press.
36. MEIKRANTZ W. & SCHLEGEL R. (1995) Apoptosis and the cell cycle. J. Cell. Biochem. 58, 160-174.
37. NAGY Z., ESIRI M.M. & SMITH A.D. (1997a) Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol. 93, 294-300.
38. NAGY Z., ESIRI M.M., CATO A.M. & SMITH A.D. (1997b) Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol. 94, 6-15.
39. NEVE R.L. & ROBAKIS N.K. (1998) Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 21, 15-19.
40. OISHI M., NAIRN A.C., CZERNIK A.J. ET AL. (1997) The cytoplasmic domain of Alzheimer's amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells. Mol. Med. 3, 111-123.
41. PARK D.S., MORRIS E.J., PADMANABHAN J., SHELANSKI M.L., GELLER H.M. & GHEENE L.A. (1998) Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J. Cell Biol. 143, 457-467.
42. PREMKUMAR D.R.D., SMITH M.A., RICHEY P.L. ET AL. (1995) Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J. Neurochem. 65, 1399-1402.
43. SCHRECK R., RIEBER P. & BAEUERLE P.A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10, 2247-2258.
44. SELKOE D.J. (1996) Amyloid á-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298.
45. SHEN J., BRONSON R.T., CHEN D.F., XIA W., SELKOE D.J. $ TONEGAWA S. (1997) Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639.
46. SMITH M.A., TANEDA S., RICHEY P.L. ET AL. (1994a) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proceedings. Natl. Acad. Sci. USA 91, 5710-5714.
47. SMITH M.A., KUTTY R.K., RICHEY P.L. ET AL (1994b) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145, 42-47.
48. SMITH T.W. & LIPPA C.F. (1995) Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J. Neuropathol. Exp. Neurol. 54, 297-303.
49. SMITH M.A., PERRY G., RICHEY P.L. ET AL. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
50. SMITH M.A., HARRIS P.L.R., SAYRE L.M., BECKMAN J.S. & PERRY G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 2653-2657.
51. SOUSA M., BARROS A., SILVA J. & TESARIK J. (1997) Developmental changes in calcium content of ultrastructurally distinct subcellular compartments of preimplantation human embryos. Mol. Human Reprod. 3, 83-90.
52. STEWART B.W. (1994) Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J. National Cancer Inst. 86, 1286-1296.
53. SUGANO T., NITTA M., OHMORI H. & YAMAIZUMI M. (1995) Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the heat shock response, independently of the cell cycle. Japanese J. Cancer Res. 86, 415-418.
54. SUZUKI T., OISHI M., MARSHAK D.R., CZERNIK A.J., NAIRN A.C. & GREENGARD P. (1994) Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J. 13, 1114-1122.
55. VINCENT I., ROSADO M. & DAVIES P. (1996) Mitotic mechanisms in Alzheimer's disease?. J. Cell Biol. 132, 413-425.
56. VINCENT I., JICHA G., ROSADO M. & DICKSON D.W. (1997) Aberrant expression of mitotic Cdc2/Cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17, 3588-3598.
57. VITO P., WOLOZIN B., GANJEI J.K., IWASAKI K., LACANA E. & D'ADAMIO L. (1996a) Requirement of the familial Alzheimer's disease gene PSo2: for apoptosis. Opposing effect of ALG-3. J. Biol. Chem. 271, 31025-31028.
58. VITO P., LACANA E. & D'ADAMIO L. (1996b) Interfering with apoptosis: Ca (2+) -binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271, 521-525.
59. WOLOZIN B., IWASAKI K., VITO P. ET AL. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713.
60. WOLOZIN B., ALEXANDER P. & PALACINO J. (1998) Regulation of apoptosis by presenilin 1. Neurobiol. Aging 19, S23-S27.
61. WONG P.C., ZHENG H., CHEN H. ET AL. (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387, 288-292.
62. YAMATSUJI T., MATSUI T., OKAMOTO T. ET AL. (1996) G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272, 1349-1352.
63. ZHANG Z., HARTMANN H., DO V.M. ET AL. (1998) Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698-702.